Bone Health News and Research

RSS

Experimental cancer drug could protect against osteoporosis and weight gain

An experimental cancer drug could stop osteoporosis and help women stay slim after the menopause – according to new research from the University of East Anglia.

7 Sep 2026

Prednisone may impair bone health in children with Duchenne muscular dystrophy

In a new study published in Scientific Reports, an international and multidisciplinary research team including Binghamton University researchers identified a set of blood proteins that may explain why the corticosteroid prednisone, although beneficial in treating Duchenne muscular dystrophy (DMD), can interfere with childhood growth and bone health.

4 Sep 2026

Phthalates may contribute to high blood pressure in pregnant women

Phthalates, which are chemicals found in plastics, personal care products and hundreds of other consumer goods, may contribute to high blood pressure in pregnant women, according to a study published in the Journal of the Endocrine Society.

10 Aug 2026

$GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes$

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

New research by UCLA Health found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.

4 Aug 2026

Blocking the Axl receptor may offer a new way to promote bone formation

Osteoporosis is one of the most common age-related bone diseases, affecting millions of people worldwide and increasing the risk of fractures, disability, and reduced quality of life.

28 Jul 2026

Study links collagen peptides to improved bone health in runners

Collagen is a protein found in skin, hair, nails, tendons, cartilage, and bones. Our bodies naturally produce collagen using the foods we eat. But, in recent years, collagen peptides have gained popularity as a supplement to support joint, hair, skin, and gut health.

22 Jul 2026

$Bone fractures often go unrecognized as early signs of osteoporosis$

Bone fractures often go unrecognized as early signs of osteoporosis

Many fractures are early-warning signs of osteoporosis. Yet in everyday clinical care they often go unrecognized and undocumented as warning signs, according to a new nationwide Austrian study by the Complexity Science Hub (CSH) and the Ludwig Boltzmann Institute for Osteology (LBI Osteology). Men are affected more often.

20 Jul 2026

New genomic map identifies hundreds of genes governing bone health

In a global breakthrough published in Nature Genetics, researchers have successfully mapped the cells and genes that regulate bone formation and loss at an unprecedented scale and discovered the critical role that blood vessel cells play in bone health.

10 Jul 2026

Lifelong violence against women linked to significantly earlier menopause

The research, published in the journal Maturitas, links trauma experienced to the onset of the menopause up to 20 months earlier and an increase in hot flushes, depression and cardiometabolic health problems.

6 Jul 2026

Scientists identify key osteoblast protein that promotes bone formation

New study identifies CAR3 as a key osteoblast protein promoting collagen mineralization, bone formation, and skeletal regeneration.

26 Jun 2026

Elite athletes with higher vitamin D show healthier lipid profiles

Higher serum 25-hydroxyvitamin D levels were independently associated with lower LDL-C, triglycerides, and lipoprotein(a) in 773 male professional athletes. The cross-sectional study cannot establish causality, but it suggests that vitamin D status may be linked to cardiovascular risk-related lipid markers, even in elite athletic populations.

23 Jun 2026

Tirzepatide activates calorie-burning brown fat to combat obesity

Tirzepatide doesn't just help people lose weight; it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

16 Jun 2026

Study identifies top predictors for weight loss using tirzepatide

One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting a weight goal were the best predictors of total weight loss, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

16 Jun 2026

GLP-1s may improve testosterone levels and sperm quality in men with obesity

GLP‑1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Global study links rising obesity to premature heart disease deaths

Researchers are warning that obesity is reshaping the global cardiovascular disease crisis, as trend data covering 204 countries reveal that heart disease now peaks in people aged 50-54 rather than the elderly and increasingly in South Asia, where rates have grown more than three times faster than global averages, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Long daily naps increase liver disease risk in diabetic patients

People with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Childhood factors causing later menarche impact lifelong adult health

Problems in adulthood such as tobacco use disorder and some conditions related to the digestive system, heart, bladder, joints and brain, are all shown to be affected by some influences that occurred in childhood, according to research presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Menopausal hormone therapy linked to stronger bone health

Women on menopausal hormonal therapy face a decreased risk of low bone mineral density compared to those not using it, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Study reveals frequent stop-and-start patterns with GLP-1 drugs

People prescribed GLP-1 medications are more likely to start-and-stop than most people assume, according to a study being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Non-hormonal menopausal medication improves mood and hot flashes

The first real-world study of the FDA-approved non-hormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research being presented Sunday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026